Predicting Clinical Outcome of 5-Fluorouracil-Based Chemotherapy for Colon Cancer Patients: Is the CpG Island Methylator Phenotype the 5-Fluorouracilresponsive Subgroup?

International Journal of Clinical Oncology - Japan
doi 10.1007/s10147-008-0854-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CpG Island Methylator Phenotype in Colorectal Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Comparison of Adverse Events During 5-Fluorouracil Versus 5-Fluorouracil/Oxaliplatin Adjuvant Chemotherapy for Stage III Colon Cancer

Cancer
Cancer ResearchOncology
2012English

Meta-Analysis of the Prognostic Value of CpG Island Methylator Phenotype in Gastric Cancer

British Journal of Surgery
Surgery
2018English

CpG Island Methylator Phenotype and Prognosis of Colorectal Cancer in Northeast China

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Individualized Predictive Signatures for 5-Fluorouracil-Based Chemotherapy in Right- And Left-Sided Colon Cancer

Cancer Science
Cancer ResearchMedicineOncology
2018English

Cyclin D1 Is Frequently Overexpressed in Microsatellite Unstable Colorectal Cancer, Independent of CpG Island Methylator Phenotype

Histopathology
MedicineForensic MedicinePathologyHistology
2008English

CpG Island Methylator Phenotype Associates With Low-Degree Chromosomal Abnormalities in Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2008English

The CpG Island Methylator Phenotype May Confer a Survival Benefit in Patients With Stage II or III Colorectal Carcinomas Receiving Fluoropyrimidine-Based Adjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Role of Cyclin Polymorphisms in Predicting Outcome of 5-Fluorouracil-Based Chemotherapy in Colorectal Cancer: One Piece in a Complex Puzzle

Pharmacogenomics
Molecular MedicineGeneticsPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy